Bookmark
Forward
QuickView for Fenoterol (compound)
PubChem
| Name: | Fenoterol |
|---|---|
| PubChem Compound ID: | 16037 |
| Description: | An adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic. |
| Molecular formula: | C17H22BrNO4 |
| Molecular weight: | 384.265 g/mol |
| Synonyms: |
1944-12-3; Partusisten; 5-(1-Hydroxy-2-((2-(4-hydroxyphenyl)-1-methylethyl)amino)ethyl)resorcinol hydrobromide; EINECS 217-742-8; Benzyl alcohol, 3,5-dihydroxy-alpha-(((p-hydroxy-alpha-methylphenethyl)amino)methyl)-, hydrobromide; Fenoterol hydrobromide; 1-(3,5-Dihydroxy-phenyl)-2-((1-(4-hydroxybenzyl)ethyl)amino)-ethanol hydrobromide; Fenoterol bromide; D01428; 1,3-Benzenediol, 5-(1-hydroxy-2-((2-(4-hydroxyphenyl)-1-methylethyl)amino)ethyl)-, HBr (9CI).
show more » |
DrugBank
Identification
| Name: | Fenoterol |
|---|---|
| Name (isomeric): | DB01288 |
| Drug Type: | small molecule |
| Description: | An adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic. |
| Synonyms: |
Phenoterol; Fenoterolum [inn-latin]
|
| Brand: | Berotec |
| Brand name mixture: | Duovent UDV(Fenoterol Hydrobromide + Ipratropium Bromide) |
| Category: | Tocolytic Agents, Adrenergic beta-Agonists, Sympathomimetics, Bronchodilator Agents |
| CAS number: | 13392-18-2 |
Pharmacology
| Indication: | Fenoterol is used for the treatment of asthma. |
|---|---|
| Pharmacology: | Fenoterol is a beta agonist designed to open up the airways to the lungs by decreasing bronchconstriction. |
| Mechanism of Action: | Beta(2)-receptor stimulation in the lung causes relaxation of bronchial smooth muscle, bronchodilation, and increased bronchial airflow. |
| Biotransformation: | Hepatic. |
| Toxicity: | Symptoms of overdose include angina (chest pain), dizziness, dry mouth, fatigue, flu-like symptoms, headache, heart irregularities, high or low blood pressure, high blood sugar, insomnia, muscle cramps, nausea, nervousness, rapid heartbeat, seizures, and tremor. |
| Affected organisms: | Humans and other mammals |
Interactions
| Food interaction: |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Drug interaction: |
|
Targets
